Résumé
We currently live in a world with a rapidly growing population and standards of care are higher than ever. Healthcare systems and companies are looking for ways to improve the quality of care they provide and to grant all patients equal access to good care. They have been testing digital therapeutics for the past ten years and during the COVID-19 pandemic, they managed to see the true value behind DTx.The latter are currently facing many access barriers of different natures given that the current healthcare systems are not adapted to handle the innovative digital therapies. Active steps are taken by developed countries to integrate DTx into healthcare and overcome the barriers to implementation. Companies from their side are developing business tactics and strategies to mitigate the barriers they face during development phases, clinical trials, launch and different commercialization aspects overcome the barriers to implementation. Companies from their side are developing business tactics and strategies to mitigate the barriers they face during development phases, clinical trials, launch and different commercialization aspects.